Dongmin (Eugene) Bang
PharmD, PhD in Bioinformatics, Senior Research Scientist @AIGENDRUG Co., Ltd.

Room 541, Bldg. 301
Seoul National University
1 Gwanak-ro, Gwanak-gu
Seoul 08826, Republic of Korea
With a dual background in pharmacy and computational biology, I focus on integrating pharmacological insight with machine learning to tackle a core challenge in drug discovery and precision medicine: extracting actionable knowledge from complex, high-dimensional, and often sparse biomedical data.
My research centers on developing knowledge-aware computational frameworks—including patient-specific gene regulatory modeling, graph-based learning, and multi-modal molecular representation—to improve therapeutic prediction, compound prioritization, and drug-likeness evaluation. These efforts prioritize model interpretability, translational generalizability, and the principled incorporation of domain knowledge into data-driven systems.
You can see my academic CV attached here.
news
Jun 29, 2025 | 🚀 Redefining Drug-Likeness with AI: ICML & ISMB Presentations Coming Up! 💊 |
---|---|
Jun 18, 2025 | 🎓 Successfully defended my dissertation entitled: “Modeling Multi-Scale Biomedical Interactions via Transfer Learning and Knowledge Integration for Personalized Medicine” 🩺🧬! |
May 01, 2025 | 🎉 One paper accepted to ICML 2025! 🚀🧠 |
Apr 08, 2025 | 🎉 Two ISMB/ECCB 2025 Papers Accepted! A Small Win for AI x Drug Discovery 🧪 |
Jan 15, 2025 | 🎉 Two Papers on Multi-modal Molecular Representation Learning Accepted! |
latest posts
selected publications
- ISMBTransfer learning of condition-specific perturbation in gene interactions improves drug response predictionBioinformatics, 2024
- Nat Commun.Biomedical knowledge graph learning for drug repurposing by extending guilt-by-association to multiple layersNature Communications, 2023